Prednisolone (prednisolone)
Last reviewed · Source: First Databank (FDB) drug data
Overview
Prednisolone is a synthetic glucocorticoid.
Prednisolone is used principally as an anti-inflammatory or immunosuppressant agent. Because prednisolone has only minimal mineralocorticoid properties, the drug is inadequate alone for the management of adrenocortical insufficiency. If prednisolone is used in the treatment of this condition, concomitant therapy with a mineralocorticoid is also required.
Generic name: prednisolone
Pronunciation: (pred-NIS-oh-loan)
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Prednisolone
Indications
The following indications are listed for Prednisolone:
- Acquired Thrombocytopenia
- Acute Exacerbation Of Multiple Sclerosis
- Acute Gouty Arthritis
- Acute Lymphoid Leukemia
- Adrenocortical Insufficiency
- Adrenogenital Disorder
- Allergic Bronchopulmonary Aspergillosis
- Allergic Rhinitis
- Angioedema
- Ankylosing Spondylitis
- Aspiration Pneumonitis
- Asthma Exacerbation
- Atopic Dermatitis
- Autoimmune Hemolytic Anemia
- Berylliosis
- Bursitis
- Congenital Adrenal Hyperplasia
- Contact Dermatitis
- Crohn's Disease
- Dermatitis Herpetiformis
- Diagnostic Test For Cushing's Syndrome
- Diamond Blackfan Anemia
- Epicondylitis
- Erythema Multiforme
- Erythroblastic Anemia
- Exfoliative Dermatitis
- Giant Cell Arteritis
- Hodgkin's Lymphoma
- Humoral Hypercalcemia Of Malignancy
- Hypersensitivity Drug Reaction
- Hypersensitivity Pneumonitis
- Idiopathic Pulmonary Fibrosis
- Idiopathic Thrombocytopenic Purpura
- Inflammatory Bowel Disease
- Juvenile Idiopathic Arthritis
- Loffler Syndrome
- Mycosis Fungoides
- Nephrotic Syndrome
- Non-Hodgkin's Lymphoma
- Ophthalmia Sympathetic
- Organ Transplant Rejection
- Pemphigus
- Pneumocystis Jirovecii Pneumonia
- Polymyalgia Rheumatica
- Primary Adrenocortical Insufficiency
- Psoriatic Arthritis
- Rheumatoid Arthritis
- Sarcoidosis
- Serum Sickness
- Severe Persistent Asthma
- Sjogren's Syndrome
- Stevens-Johnson Syndrome
- Synovitis
- Systemic Dermatomyositis
- Systemic Lupus Erythematosus
- Tendonitis
- Tenosynovitis
- Thyroiditis
- Trichinosis
- Ulcerative Colitis
Also known as: Aase Syndrome, Acquired Hemolytic Anemia Due To Antibodies, Acute Articular Gout, Acute Exacerbation Of Ms, Acute Gout Attack, Acute Gout Flare, Acute Lymphatic Leukemia, Acute Lymphocytic Leukemia, Acute Lymphogenous Leukemia, Acute Relapse Of Ms, Acute Relapse Of Multiple Sclerosis, Acute Uratic Arthritis, Addison Melanoderma, Adrenal Cortical Hypofunction, Adrenal Failure, Adrenal Insufficiency, Adrenocortical Hypofunction, Adrenogenital Syndrome, Aggravation Of Asthma, Allergic Alveolitis, Anemia Lymphatica, Angioneurotic Edema, Arthritis Deformans, Arthrosis Deformans, Asthenia Pigmentosa, Atopic Eczema, Atrophedema, Axial Spondyloarthritis With Radiographic Sacroiliitis, Bannister's Disease, Bekhterev's Arthritis, Bekhterev's Disease, Bekhterev's Spondylitis, Besnier-Boeck-Schaumann Disease, Besnier-Boeck-Schaumann Syndrome, Blackfan Diamond Syndrome, Blistering Skin Disease, Boeck's Disease, Boeck's Sarcoid, Bullous Dermatitis Herpetiformis, Chronic Adrenocortical Insufficiency, Colitis Ulcerativa, Congenital Erythroid Hypoplastic Anemia, Congenital Hypoplastic Anemia, Congenital Pure Red Cell Aplasia, Congenital Suprarenal Hyperplasia, Constitutional Erythroid Hypoplasia, Cranial Arteritis, Cryptogenic Fibrosing Alveolitis, Deficiency In Bone Marrow Erythroblasts, Dermatitis Venenata, Diagnostic Procedure For Cushing's Syndrome, Disseminated Lupus Erythematosus, Disseminated Neurodermatitis, Drug Hypersensitivity Reaction, Drug-Induced Hypersensitivity, Drug-Induced Hypersensitivity Reaction, Erythema Exfoliativa, Erythema Polymorphe, Erythroblastopenia, Erythroderma Exfoliativa, Erythrogenesis Imperfecta, Exacerbation Of Asthma, Exfoliative Eczema, Exfoliative Erythroderma, Extracranial Arteritis, Extrinsic Allergic Alveolitis, Giant Urticaria, Giant-Cell Arteritis, Gougerot-Sjogren Disease, Granulomatous Arteritis, Hebra's Disease, Herpes Iris, Hodgkin's Disease, Horton's Arteritis, Hypercalcemia Associated With Cancer, Hypercalcemia Associated With Malignancy, Hypercalcemia Of Malignancy, Hypersensitivity Pneumonia, Hypoadrenalism, Hypocorticoidism, Idiopathic Fibrosing Alveolitis, Immune Thrombocytopenia, Immune Thrombocytopenia Purpura, Inflammation Of The Synovial Membrane, Inflammation Of The Synovium, Johnson-Stevens Syndrome, Juvenile Ra, Juvenile Rheumatoid Arthritis, Loeffler Syndrome, Loffler's Syndrome, Lupus Erythematosus Syndrome, Lymphoblastic Leukemia, Malignant Hypercalcemia, Marie-Strumpell Disease, Marie-Strumpell Spondylitis, Melasma Addisonii, Mendelson's Syndrome, Milton's Disease, Multiple Sclerosis Exacerbation, Nodose Rheumatism, Non-Hodgkin's Type Lymphoma, Organ Transplant Rejection Reaction, Periodic Urticaria, Pie Syndrome, Pneumocystis Jirovecii (Carinii) Pneumonia, Pneumocystis Pneumonia, Pneumocystosis Jirovecii Pneumonia, Post Infectious Thrombocytopenia, Primary Adrenal Deficiency, Primary Adrenal Insufficiency, Primary Corticoadrenal Insufficiency, Primary Failure Adrenocortical Insufficiency, Psoriasis Arthropica, Psoriatic Arthropathy, Pulmonary Pneumocystosis, Purpura Hemorrhagica, Quincke's Disease, Quincke's Edema, Regional Enteritis, Regional Ileocolitis, Rheumatic Arthritis, Rheumatic Gout, Rheumatoid Spondylitis, Rhizomelic Spondylitis, Rhizomelic Spondylosis, Schaumann's Syndrome, Secondary Thrombocytopenia, Serum Sickness-Like Reaction, Sicca Syndrome, Simple Pulmonary Eosinophilia, Sjogren's Disease, Spondylosis Deformans, Strumpell-Marie Disease, Suprarenal Failure, Sympathetic Ophthalmia, Temporal Arteritis, Tendinitis, Tendinous Synovitis, Tendosynovitis, Tendovaginitis, Tenontolemmitis, Tenontothecitis, Tenovaginitis, Transplant Rejection, Trichinella Spiralis Infection, Trichinellosis, Trichiniasis, Urticaria Tuberosa, Werlhof's Disease.
Dosing
The dosage of prednisolone and its derivatives depends on the condition being treated and the response of the patient. Dosage for infants and children should be based on the severity of the disease and the response of the patient rather than on strict adherence to dosage indicated by age, body weight, or body surface area. After a satisfactory response is obtained, dosage should be decreased in small decrements to the lowest level that maintains an adequate clinical response. Patients should be continually monitored for signs that indicate dosage adjustment is necessary, such as remissions or exacerbations of the disease and stress (surgery, infection, trauma). When long-term oral prednisolone therapy is necessary, an alternate-day dosage regimen should be considered. Following long-term therapy, prednisolone should be withdrawn gradually.
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
There is no enhanced messaging for this drug.
There are no contraindication contraindications for this drug.
There are no severe contraindications for this drug.
There are no moderate contraindications for this drug.
Adverse reactions
There is no enhanced messaging for this drug.
There are no severe adverse reactions for this drug.
There are no less severe adverse reactions for this drug.
Precautions
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
ICD codes
No ICD codes are available for this drug.
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.